1910 Genetics Inc.
Biotechnology company · Cambridge, Massachusetts, United States
1910 Genetics Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2018. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $546,376 in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $26 million sold in a notice filed in 2021.
1910 Genetics at a glance
What does 1910 Genetics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $546,376 in total (2021). NIH funding came from the National Institute of Neurological Disorders and Stroke.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $25.7 million sold (2021).
Frequently asked questions about 1910 Genetics
Where is 1910 Genetics headquartered?
1910 Genetics Inc. is headquartered in Cambridge, Massachusetts, United States.
What does 1910 Genetics do?
1910 Genetics Inc. is a biotechnology company.
When was 1910 Genetics founded?
The earliest incorporation on record for 1910 Genetics Inc. is in 2018, according to public company registers.
Similar companies
- Editas Medicine, Inc.Cambridge, Massachusetts, United States
- Moderna, Inc.Cambridge, Massachusetts, United States
- Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
- Beam Therapeutics Inc.Cambridge, Massachusetts, United States
- Genzyme CorpCambridge, Massachusetts, United States
- Neutrolis Inc.Cambridge, Massachusetts, United States
- Biogen Inc.Cambridge, Massachusetts, United States
- Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences